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Abstract
High tibial osteotomy (HTO) is a well-established treatment for medial compartmental knee
osteoarthritis. Several microRNAs (miRNAs) are involved in osteoarthritis progression and
are useful as osteoarthritis-related biomarkers. In this prospective study, we investigated dif-
ferentially expressed microRNAs in the synovial fluid (SF) before and after HTO in patients
with medial compartmental knee osteoarthritis to identify microRNAs that can be used as
prognostic biomarkers. We used miRNA-PCR arrays to screen for miRNAs in SF samples
obtained preoperatively and 6 months postoperatively from 6 patients with medial compart-
mental knee osteoarthritis who were treated with medial open wedge HTO. Differentially
expressed miRNAs identified in the profiling stage were validated by real-time quantitative
PCR in 22 other patients who had also been treated with HTO. All patients radiographically
corresponded to Kellgren-Lawrence grade II or III with medial compartmental osteoarthritis.
These patients were clinically assessed using a visual analogue scale and Western Ontario
McMaster Universities scores. Mechanical axis changes were measured on standing ante-
roposterior radiographs of the lower limbs assessed preoperatively and at 6 months postop-
eratively. Among 84 miRNAs known to be involved in the inflammatory process, 14 were
expressed in all SF specimens and 3 (miR-30a-5p, miR-29a-3p, and miR-30c-5p) were dif-
ferentially expressed in the profiling stage. These 3 miRNAs, as well as 4 other miRNAs
(miR-378a-5p, miR-140-3p, miR-23a-3p, miR-27b-3p), are related to osteoarthritis progres-
sion. These results were validated in the SF from 22 patients. Clinical and radiological out-
comes improved after HTO in all patients, and only 2 miRNAs (miR-30c-5p and miR-23a-
3p) were significantly differentially expressed between preoperative and postoperative 6-
month SF samples (p = 0.006 and 0.007, respectively). Of these two miRNAs, miR-30c-5p
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correlated with postoperative pain relief. This study provides potential prognostic miRNAs
after HTO and further investigations should be considered to determine clinical implications
of these miRNAs.
Introduction
High tibial osteotomy (HTO) is a well-known treatment modality for active patients with
medial compartmental osteoarthritis (OA) of the knee [1,2]. Several studies have shown a cor-
relation between HTO and regeneration of the degenerated cartilage, which is thought to
occur through the realignment of the mechanical axis in medial compartmental knee OA. As a
result, HTO offers excellent intermediate and long-term survival rates [3,4]. Moreover, a cor-
relation has been reported between visible improvement of the articular surface and the degree
of correction with HTO [5].
The pathogenesis of OA is thought to be a complex and multifactorial process caused by
genetic, mechanical, and environmental factors. Recently, the effect of dysregulation, which
occurs at the molecular level during the pathogenic process of OA, has gained increased atten-
tion [6]. Environmental factors induce epigenetic mechanisms that independently regulate
genomic activity in the DNA sequence and alter the expression of genes involved in disease
development [7]. MicroRNAs (miRNAs), which are small non-coding RNAs composed of 19–
25 nucleotides, regulate gene expression post-transcriptionally through mRNA degradation or
translational suppression by binding to the 30-UTR of target genes [8]. The role of miRNAs in
cartilage degeneration has been previously reported [9,10]. Most published studies that quanti-
fied miRNA expression in OA have focused on tissues or cell lines. However, miRNAs have
also been identified in the circulatory body fluids of patients with other pathologies [11,12]
such that the levels of some circulating miRNAs have been associated with the diagnosis and
prognosis of several diseases [13].
Most studies on HTO in medial compartmental knee OA have focused on the change in the
mechanical load on the knee joint resulting from the realignment of the mechanical axis (MA)
[14,15]. Regeneration of the degenerated articular cartilage in the medial compartment in
medial compartmental knee OA can be expected following HTO without the need for any
additional procedures, although the detailed mechanism is still unclear. Although there are
many studies related to HTO in medial compartmental knee OA or miRNA expression in OA,
only a small amount of information is available on the changes that occur in miRNA expres-
sion after HTO in medial compartmental knee OA and their clinical implication. Nonetheless,
any changes in miRNA expression in the synovial fluid (SF) could be related to the change in
the MA following HTO and subsequent cartilage regeneration. Thus, these miRNAs could be
used as biomarkers to predict the prognosis after HTO.
This prospective study was conducted to determine which miRNAs in the SF are signifi-
cantly differentially expressed after HTO for medial compartment knee OA and to identify the
miRNAs that can serve as biomarkers related to overall prognosis.
Materials and methods
Study subjects
Patients with medial compartment knee OA who underwent HTO between November 2015
and February 2017 were prospectively enrolled in this study. First, 6 patients were recruited
for the profiling stage; these patients were all females with a mean age of 57.7 years (52–65
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years). Medial compartmental knee OA was confirmed by plain radiographs and scored
according to the Kellgren-Lawrence grade (K-L grade) (Table 1). All patients were K-L grade
II or III OA only in the medial compartment of the affected knee. For miRNA validation, 22
patients were recruited, including 19 female and 3 male patients with a mean age of 56.8 years
(46–65 years). All patients were K-L grade II or III OA only in the medial compartment
(Table 2). SF specimens were collected from each patient in the operating room immediately
prior to undergoing the HTO procedure. Six-month SF specimens were collected in an outpa-
tient clinic at the 6-month follow-up postoperatively.
Clinical evaluations to determine factors such as pain and functional improvement of the
patients were performed using a visual analogue scale (VAS) score and the Western Ontario
McMaster Universities (WOMAC) score, both preoperatively and 6 months postoperatively.
Radiological assessment was performed using standing full-length anteroposterior radiographs
of the lower limbs, which were taken preoperatively and 6 months postoperatively in all cases.
These radiographs were taken to ensure that the patella was directly facing the front. Radio-
graphic changes after HTO were evaluated by measuring the MA and weight bearing line
(WBL) ratio. The WBL was defined as the perpendicular distance from the WBL to the medial
edge of the tibial plateau divided by the width of the tibial plateau. The MA was defined as the
angle subtended by a line drawn from the center of the femoral head to the center of the knee
and a line drawn from the center of the knee to the center of the talus. The WBL was drawn
from the center of the femoral head to the center of the superior articular surface of the talus
[16].
Sampling strategy and miRNA analysis
RNA extraction from SF. First, 5 ml of SF was collected in EDTA tubes from all patients,
and the plasma was separated by centrifugation within 4 h of collection to ensure consistent
Table 1. Data of 6 patients at the profiling stage.
Serial number Gender Age
(years)
Body mass index (kg/m2) Kellgren-Lawrence grade Visual Analogue Scale (VAS) WOMAC Score
Total Pain Stiffness Function
1 F 57 28.4 II 6 54 13 4 37
2 F 55 23.9 II 5 10 1 0 9
3 F 61 22.8 III 7 56 8 6 42
4 F 56 27.9 III 7 42 9 3 30
5 F 65 30.2 III 3 14 0 0 14
6 F 52 26.0 III 4 33 9 3 21
https://doi.org/10.1371/journal.pone.0227596.t001





Body mass index (kg/m2) Kellgren-Lawrence grade Visual Analogue Scale (VAS) WOMAC Score
Total Pain Stiffness Function
1 F 50 30.5 III 3 21 2 2 17
2 F 46 33.3 III 7 22 3 2 17
3 F 51 25.5 II 9 59 14 3 42
4 F 56 21.8 III 8 28 5 5 18
5 F 57 28.4 II 6 54 13 4 37
6 F 55 23.9 II 5 10 1 0 9
7 F 61 22.8 III 7 56 8 6 42
8 F 56 27.9 III 7 42 9 3 30
https://doi.org/10.1371/journal.pone.0227596.t002
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pre-analytical conditions for all samples. All samples were stored at -80˚C and were not sub-
jected to any freeze–thaw cycles before use. Total RNA was isolated from each specimen using
the miRNeasy Serum/Plasma Kit (Qiagen, Germany), according to the manufacturer’s instruc-
tions. The samples were immediately stored at -80˚C until further analysis.
Profiling by miRNAs array analysis. Reverse transcription was conducted with 2 μl RNA
in 10 μl reactions using the miScript II RT Kit (Qiagen, Germany), according to the manufac-
turer’s instructions. cDNA from miRNA was amplified using the miScript miRNA PCR Array
(MIHS-105Z, Qiagen, Germany). Real-time PCR was performed on the StepOnePlusTM Real
Time PCR System (Applied Biosystems, USA) using the miScript SYBR Green PCR Kit (Qia-
gen, Germany). Thermal cycling conditions were 95˚C for 15 min followed by 40 cycles of
95˚C for 15 s, 55˚C for 30 s, and 70˚C for 30 s, respectively. The data were analyzed using the
PCR array data analysis tools (Qiagen, Germany). These panels contained primers for detec-
tion of the 84 most highly expressed miRNAs in the human body fluid (Fig 1). Real-time PCR
was performed according to the manufacturer’s instructions. In each 96-well plate, cDNAs
from preoperative and postoperative 6-month SF specimens from each patient were amplified
in parallel. Expression values were calculated using the 2-ΔCt method, and the mean and stan-
dard deviation (SD) of the three technical replicates are shown in Table 3. Additionally, the
fold changes indicating the value of the change in the expression of miRNAs between the pre-
operative and postoperative 6-month time points were also calculated.
Validation RT-qPCR. To analyze the expression of these miRNAs, real-time PCRs were
performed using the specific miScript Primer Assay (Qiagen, Germany). To normalize the
expression of the miRNAs being validated, the GeNorm algorithm (GenEx, Qiagen, Germany)
was used. SNORD61 was used as an endogenous reference gene [17].
Ethics statement
This study protocol was approved by the local Institutional Review Board/ Ethics Committee
of Hallym University Sacred Heart Hospital (2015-I101), and it was conducted in compliance
with the Declaration of Helsinki. Written informed consent was obtained from each patient,
Fig 1. Study design. Three candidate miRNAs were identified in synovial fluid samples collected from 6 patients preoperatively and postoperatively after high tibial
osteotomy. After adding 4 miRNAs from published literature, a total of 7 miRNAs in 22 patients were validated.
https://doi.org/10.1371/journal.pone.0227596.g001
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Table 3. miRNA expression levels in synovial fluid.
miRNA Preop. Postop. 6 months Fold
Regulation
p-value
ΔCt 2-ΔCt ΔCt 2-ΔCt
hsa-miR-30a-5p 0.48 ± 0.71 0.72 0.71 ± 1.00 1.58 2.20 0.028�
hsa-miR-29a-3p 0.33 ± 1.36 0.80 1.36 ± 1.15 2.47 3.09 0.037�
hsa-miR-30c-5p 0.84 ±0.80 0.56 0.80 ± 1.49 1.25 2.23 0.047�
hsa-miR-144-3p 1.72 ± 1.33 0.30 1.33 ± 0.63 0.77 2.53 0.052
hsa-miR-195-5p -1.58 ± 0.89 3.00 0.89 ± 0.80 1.20 -2.49 0.058
hsa-let-7c-5p -0.44 ± 1.64 1.35 1.64 ± 1.14 5.36 3.96 0.058
hsa-let-7e-5p 0.90 ± 1.51 0.54 1.51 ± 1.04 1.39 2.59 0.061
hsa-miR-16-5p -2.19 ± 1.36 4.57 1.36 ± 0.62 1.46 -3.14 0.062
hsa-miR-543 3.08 ± 2.40 0.12 2.40 ± 1.52 0.59 5.00 0.066
hsa-miR-98-5p 3.08 ± 2.40 0.12 2.40 ± 1.77 0.55 4.65 0.071
hsa-miR-1324 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-211-5p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-300 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-301a-3p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-301b-3p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-302a-3p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-302b-3p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-302c-3p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-340-5p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-34c-5p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-372-3p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-373-3p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-381-3p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-410-3p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-449b-5p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-511-5p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-513b-5p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-519c-3p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-519d-3p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-520d-3p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-520e 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-524-5p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-545-3p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-548c-3p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-548d-3p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-548e-3p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-590-5p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-607 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-655-3p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-875-3p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-9-5p 3.08 ± 2.40 0.12 2.40 ± 1.83 0.54 4.56 0.072
hsa-miR-454-3p 3.01 ± 2.31 0.12 2.31 ± 1.83 0.54 4.34 0.072
hsa-miR-128-3p 2.84 ± 2.15 0.14 2.15 ± 1.83 0.54 3.88 0.074
hsa-miR-497-5p 2.98 ± 2.40 0.13 2.40 ± 1.83 0.54 4.26 0.075
hsa-miR-449a 3.07 ± 2.40 0.12 2.40 ± 1.98 0.62 5.20 0.076
hsa-miR-101-3p 2.53 ± 1.93 0.17 1.93 ± 1.68 0.56 3.26 0.077
(Continued)
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Table 3. (Continued)
miRNA Preop. Postop. 6 months Fold
Regulation
p-value
ΔCt 2-ΔCt ΔCt 2-ΔCt
hsa-miR-374a-5p 2.69 ± 2.18 0.16 2.18 ± 1.83 0.54 3.48 0.080
hsa-miR-17-5p 1.26 ± 0.79 0.42 0.79 ± 0.76 0.74 1.77 0.082
hsa-miR-34a-5p 2.15 ± 1.97 0.23 1.97 ± 1.69 0.61 2.73 0.084
hsa-miR-20b-5p 1.91 ± 1.30 0.27 1.30 ± 1.80 0.57 2.15 0.085
hsa-miR-181d-5p 2.21 ± 1.62 0.22 1.62 ± 1.83 0.54 2.50 0.091
hsa-miR-424-5p 1.92 ± 1.29 0.26 1.29 ± 1.69 0.56 2.13 0.093
hsa-miR-130a-3p 2.03 ± 1.45 0.24 1.45 ± 1.83 0.54 2.21 0.094
hsa-miR-202-3p 2.44 ± 2.04 0.18 2.04 ± 1.89 0.60 3.26 0.098
hsa-miR-106b-5p 1.99 ± 1.50 0.25 1.50 ± 1.83 0.54 2.15 0.099
hsa-miR-125b-5p -0.71 ± 1.90 1.63 1.90 ± 0.88 5.40 3.31 0.101
hsa-miR-145-5p 2.64 ± 2.16 0.16 2.16 ± 1.88 0.57 3.57 0.104
hsa-miR-30b-5p 2.25 ± 2.18 0.21 2.18 ± 1.41 0.61 2.90 0.108
hsa-miR-181c-5p 1.94 ± 1.69 0.26 1.69 ± 1.83 0.54 2.07 0.135
hsa-miR-130b-3p 1.60 ± 1.25 0.33 1.25 ± 1.59 0.58 1.75 0.138
hsa-let-7g-5p 1.52 ± 1.42 0.35 1.42 ± 1.30 0.74 2.13 0.140
hsa-miR-656-3p 0.90 ± 2.50 0.53 2.50 ± 1.94 2.35 4.39 0.147
hsa-miR-186-5p 0.96 ± 0.60 0.51 0.60 ± 0.98 0.73 1.42 0.150
hsa-miR-125a-5p -0.55 ± 1.19 1.46 1.19 ± 1.34 3.24 2.22 0.169
hsa-miR-181b-5p -0.25 ± 0.91 1.19 0.91 ± 0.62 0.77 -1.55 0.173
hsa-miR-19a-3p 1.04 ± 0.99 0.49 0.99 ± 1.24 0.68 1.40 0.231
hsa-miR-181a-5p 0.99 ± 0.74 0.51 0.74 ± 1.17 0.65 1.29 0.235
hsa-let-7a-5p -0.28 ± 1.40 1.22 1.40 ± 1.30 2.17 1.78 0.237
hsa-miR-29c-3p 0.79 ± 1.49 0.58 1.49 ± 2.10 0.74 1.28 0.276
hsa-miR-23a-3p -3.45 ± 1.92 10.95 1.92 ± 2.19 18.13 1.65 0.310
hsa-miR-93-5p 1.09 ± 1.21 0.47 1.21 ± 1.02 0.68 1.45 0.343
hsa-miR-29b-3p 2.03 ± 1.81 0.24 1.81 ± 1.53 0.59 2.41 0.351
hsa-let-7f-5p 0.26 ± 0.94 0.84 0.94 ± 1.02 1.16 1.38 0.355
hsa-let-7i-5p 0.95 ± 0.88 0.52 0.88 ± 1.83 0.54 1.04 0.361
hsa-miR-23b-3p 0.18 ± 1.91 0.88 1.91 ± 1.30 1.67 1.89 0.434
hsa-miR-15a-5p 1.55 ± 1.62 0.34 1.62 ± 1.83 0.54 1.58 0.446
hsa-miR-30e-5p 0.22 ± 1.13 0.86 1.13 ± 1.49 1.01 1.18 0.481
hsa-miR-19b-3p 1.34 ± 1.49 0.39 1.49 ± 1.59 0.58 1.47 0.594
hsa-let-7b-5p -2.92 ± 2.01 7.58 2.01 ± 0.99 11.19 1.48 0.782
hsa-miR-15b-5p 0.27 ± 0.85 0.83 0.85 ± 0.76 0.82 -1.01 0.841
hsa-miR-20a-5p 0.96 ± 1.71 0.51 1.71 ± 0.66 0.76 1.48 0.845
hsa-miR-21-5p -4.44 ± 1.01 21.75 1.01 ± 0.80 22.94 1.05 0.952
hsa-let-7d-5p 0.51 ± 1.54 0.70 1.54 ± 1.07 0.87 1.24 0.992
hsa-miR-30d-5p -0.30 ± 1.11 1.23 1.11 ± 0.92 1.34 1.08 0.999
Values are given as the mean ± standard deviation.
�p-value < 0.05
https://doi.org/10.1371/journal.pone.0227596.t003
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Statistical analysis
Statistical analyses were performed using SPSS1 software version 23 (IBM Corporation,
Armonk, NY, USA). Paired t-tests for the levels of miRNAs (ΔCt) and a nominal p-
value < 0.05 were used in the profiling stage, and Bonferroni corrected p-values (0.05/7) were
used in the validation stage. To compare the changes in postoperative miRNAs levels with clin-
ical and radiologic outcomes, correlation analysis using the Spearman rank test was performed
considering covariates, including age, gender, BMI, preoperative K-L grade, and preoperative
lower leg alignment. Wilcoxon signed-rank test was used for the comparison of clinical out-
comes between preoperative and postoperative values.
Results
Identification of differentially expressed miRNAs in the profiling stage
A panel of 84 miRNAs and controls were profiled in SF specimens from 6 patients with medial
compartment OA. The expression results for the 84 miRNAs based on biological groups are
shown in a heat map (Fig 2), and the PCR array analysis revealed 14 of the 84 target miRNAs
in all SF specimens. Only 3 miRNAs, miR-30a-5p, miR-29a-3p, and miR-30c-5p, were upregu-
lated with a significant fold change, and these were included in the validation testing (Table 3).
Validation stage: Expression of 7 miRNAs in SF samples acquired
preoperatively and 6 months postoperatively in 22 patients who underwent
HTO
To further validate our profiling results, the expression of a total of 7 miRNAs, the 3 identified
in the profiling stage and 4 other miRNAs, miR-378a-5p, miR-140-3p, miR-23a-3p, and miR-
27b-3p, which are reported to be related to the progression of OA, were measured in the SF
that was acquired preoperatively and at 6 months postoperatively in 22 patients using RT-
qPCR analysis. Of the 7 miRNAs, 4 miRNAs, miR-30c-5p, miR-378a-5p, miR-23a-3p and
miR-27b-3p, were differentially expressed preoperatively and 6 months postoperatively when
normalized to the expression of SNORD61 (Fig 3). When the p-values were corrected by the
Bonferroni method, only 2 miRNAs, miR-30c-5p and miR-23a-3p, showed a significantly pos-
itive fold change (Table 4).
Comparison of clinical and radiological outcomes preoperatively and 6
months postoperatively in 22 patients
Clinical outcomes assessed using a VAS and WOMAC questionnaire were significantly
improved 6 months postoperatively compared to the preoperative values (Table 5).
Preoperative pain, functional disability, and lower leg varus knee alignment were signifi-
cantly improved 6 months after index surgery in 22 patients.
Correlation between demographic and clinical data and the expression of
miRNAs
There was no significant correlation between demographic data, including age, gender, and
body mass index, and the expression of the 7 miRNAs. Moreover, there was no significant cor-
relation between the extent of radiologic correction and expression of the 7 miRNAs investi-
gated. Only the extent of pain on the VAS scale at 6 months postoperatively was significantly
lower along with the increased expression of 4 miRNAs [miR-30c-5p (correlation coefficient
-0.453, p = 0.034), 27b-3p (correlation coefficient -0.449, p = 0.036), 140-3p (correlation
Synovial fluid microRNAs after high tibial osteotomy
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coefficient -0.489, p = 0.021), and 30a-5p (correlation coefficient -0.480, p = 0.024)] (S1 Table).
miR-30c-5p was the only biomarker that correlated with significant fold changes after Bonfer-
roni correction and clinical symptoms such as postoperative pain.
Discussion
Even with pre-existing arthritis in the medial compartment of the knee, many studies have
shown improvement of articular cartilage after HTO [5,18]. Second-look arthroscopic assess-
ment after HTO has been used to provide evidence of cartilage regeneration and mechanical
improvement, which proves the effectiveness of the operation on cartilage regeneration,
although the underlying mechanism is unknown. Advanced techniques using novel circulating
miRNA signatures have led to the use of miRNAs as promising biomarkers. These miRNAs
were previously shown to be either diagnostic factors or underlying causative factors [19, 20].
Our study was designed to identify SF miRNAs in patients with improved medial compart-
ment OA using a comprehensive array approach. A systemic, array-based miRNA analysis was
performed on SF samples from 6 patients preoperatively and postoperatively. Consistently
detectable miRNAs that were significantly different after HTO were chosen for further valida-
tion of the preoperative and postoperative SF samples obtained from 22 patients. Among the
84 analyzed miRNAs, 14 miRNAs were detected in the SF of 6 patients, with 3 of these miR-
NAs, miR-30a-5p, miR-29a-3p and miR-30c-5p, showing significant fold changes after HTO.
miR-30a-5p has been previously implicated in the progression of lung [21], colorectal [22],
and other types of cancers. Previously, the miR-30a-5p family has been found to be involved in
the cardiovascular pathophysiology that leads to myocardial infarction [23, 24]. miR-30a-5p is
also associated with rheumatoid arthritis and inflammation in septic conditions [25, 26]. Shen
et al. reported that miR-30a-5p is highly expressed in the cartilage of patients with
Fig 2. Heat map showing the expression levels of 84 target miRNAs from a miRNA PCR array screening of
synovial fluid collected from 6 patients preoperatively and at 6 months postoperatively.
https://doi.org/10.1371/journal.pone.0227596.g002
Fig 3. Box plot showing the interquartile range and median of expression levels of miR-30a-5p, miR-29a-3p, miR-30c-5p, miR-378a-5p, miR-23a-3p, miR-27b-3p,
and miR-140-3p at the validation stage. The values represent the relative levels normalized to the levels of the reference gene SNORD61.
https://doi.org/10.1371/journal.pone.0227596.g003
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osteoarthritis, and its high expression can block chondrocytes, which induces the apoptosis of
chondrocytes by targeting protein kinase B [27]. However, Caserta et al. noted that circular
miR-30a-5p is inversely related to pro-inflammatory mediators, such as interleukin-1β and
interleukin-6 [26]. In our study, miR-30a-5p was highly expressed in the preoperative SF sam-
ples of patients with OA and showed significant changes at the 6-month follow-up appoint-
ment, but no significant change was found in the validation.
Studies have shown the association between miR-29a-3p and ankylosing spondylitis (AS)
[28, 29]. Although data on miR-29a-3p levels in AS are inconsistent, Prajzlerova et al. reported
that patients with advanced-stage AS with extensive bone formation have higher levels of
TGF-β, as well as miR-29a suppression and increased bone formation [30]. In addition, Sox9
represses the expression of miR-29a-3p in chondrocytes [31]. In our study, miR-29a-3p signifi-
cantly increased after HTO, which is consistent with these previous investigations. miR-30c-
5p has mainly been reported in relation to cancers [32, 33]; however, studies on chronic
inflammatory disease have shown its involvement in endothelial dysfunction [34] and macro-
phage-mediated inflammation [35]. miR-30c-5p suppresses inflammatory pathways and is
involved in related organs. Members of the miR-30 family are associated with the pathology of
human OA, as highlighted in a previous study [36]. Moreover, Kung et al. showed that miR-
30c-5p is an important potential therapeutic target in OA owing to its role in the disease pro-
gression and it can be targeted throughout a wide therapeutic window to reduce the patho-
genic development of OA. In their study, miR-30c-5p was significantly down-regulated in the
Table 4. Fold changes of the expression of miRNAs at the profiling and validation stages.
Profiling stage using microarray Validation stage
using real-time PCR
miR Name Fold change p-value Fold change p-value
has-miR-30a-5p 2.20 0.028 2.65 0.101
has-miR-29a-3p 3.09 0.037 3.59 0.062
has-miR-30c-5p 2.23 0.047 3.59 0.007�
has-miR-378a-5p - - 4.92 0.023
has-miR-23a-3p - - 4.90 0.006�
has-miR-27b-3p - - 6.16 0.012
has-miR-140-3p - - 2.65 0.101
�Paired t-test. A Bonferroni corrected p-value < 0.0071 (0.05/7), which is marked with an asterisk, was considered
statistically significant.
https://doi.org/10.1371/journal.pone.0227596.t004




Mechanical axis -5.4 ± 2.3 +2.6 ± 1.7 <0.001
(-: varus, +: valgus)
Weight-bearing line ratio (%) 18.6 ± 7.2 59.5 ± 9.2 <0.001
VAS 6.0 ± 2.0 2.6 ± 1.2 <0.001
WOMAC Total 38.9 ± 15.1 24.3 ± 12.0 0.001
Pain 8.0 ± 4.2 4.5 ± 2.6 0.003
Stiffness 3.4 ± 1.8 2.0 ± 1.5 0.008
Function 27.4 ± 10.3 17.8 ± 9.2 0.001
�p-value < 0.05
https://doi.org/10.1371/journal.pone.0227596.t005
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mouse OA model, and Npr3, an experimentally validated therapeutic target, was confirmed by
bioinformatics analysis [37]. In our study, since miR-30c-5p was found to regulate OA, our
findings are consistent with the results of previous studies. The correlations of the 3 miRNAs
evaluated in our study were inconsistent with those reported in previous studies. Nonetheless,
these miRNAs can be considered common factors in the inflammatory response related to OA
of the knee; however, in this study, we focused on SF samples. Thus, it is possible that the path-
ogenesis of regulation could be different from the processes examined in previous studies.
Along with the 3 identified miRNAs, 4 additional previously reported miRNAs were vali-
dated in 22 patients. The changes in clinical symptoms and radiological measurements were
used to identify specific miRNAs related to improved outcomes. The 4 miRNAs added in the
validation phase were identified in circulating miRNA signatures in OA knee SF samples [38,
39]. These are known to be circulating miRNAs that are differentially expressed in OA.
Among the 7 miRNAs, 1 from the profiling stage, miR-30c-5p, and 3 added at the validation
stage, miR-378a-5p, miR-23a-3p and miR-27b-3p, showed significant changes. Therefore, our
results were consistent with those of previous OA studies that used SF samples, except for
miR-140-3p, which showed a difference after HTO, albeit statistical significance was not
observed. Furthermore, Yang et al. also reported that the expression of miR-140 in SF was sig-
nificantly reduced in patients with OA [40]. After Bonferroni correction, however, only 2 miR-
NAs showed significant differences: miR-30c-5p from the profiling phase and miR-23a-3p
from the validation phase. A previous study showed that IL-1β contributes to the release of
miR-23a-3p in the SF [38]; however, our patients had a K-L grade of II or III. Hence, this find-
ing is different from that of our present study on the progression of OA. miR-378a-5p is highly
expressed in late OA, and miR-27b-3p also shows a high fold change in late OA/early OA.
Therefore, these two miRNAs may not have shown any significant difference in our study for
patients with early and late medial compartment knee OA [38]. miR-30c-5p has not been eval-
uated in OA, but it might be an important SF miRNA in medial compartment knee OA, as
previously noted in this study.
For clinical relevance, possible correlations between improvements in radiological and
functional outcomes and the levels of 7 miRNAs were analyzed. None of the 7 miRNAs was
correlated with age, gender, or body mass index data. Four miRNAs correlated with the post-
operative VAS score; however, only miR-30c-5p showed significant fold changes that corre-
lated with the postoperative VAS score. The subjective nature of pain and inconsistencies
observed during the follow-up may explain this result. Nevertheless, the importance of pain as
an outcome of clinical evaluation cannot be disregarded [41]. Moreover, these clinical correla-
tions were only measured with 22 patients, so an evaluation with a larger cohort should also be
considered. These results do not definitively prove an association between SF miRNAs and
HTO in patients with medial compartment knee OA; however, based on the data presented in
this study, we hypothesize that differences in miRNA expression in SF reflect miRNA changes
at medial compartment knee OA sites and are related to the inflammatory process.
There are some limitations to our study. In the profiling phase, we can use only 84 miRNAs
panel, so 84 miRNAs were screened. To compensate for this, several important miRNAs
reported to be related to the progression of osteoarthritis on literature were added in the vali-
dation phase. Further studies involving larger patient cohorts are needed to confirm the find-
ings presented in this study, as only a small proportion of the SF miRNAs has been analyzed.
Additionally, there was no positive control in our study. A positive control may be needed as
the change of each miRNA in the SF would be a result of surgical intervention and not entirely
specific to HTO. To account for this, we not only compared preoperative and postoperative
expression of miRNAs but also compared clinical and radiologic improvements specific to
HTO. Finally, this study focused on miRNAs related to the improvement of OA after HTO
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intervention; however, the underlying mechanisms between miRNAs and post-HTO progno-
sis were not evaluated. This study provides fundamental basic research outputs to identify
potential prognostic miRNAs based on the change of miRNA’s expressions after HTO in
medial compartmental knee OA. Further investigations are required to determine clinical
implications of the change of these miRNAs’ expressions after HTO.
Biomarkers are used to evaluate OA improvement in patients in addition to clinical symp-
toms and radiologic assessments. To the best of our knowledge, this study is the first to screen
miRNAs in the SF from patients with medial compartment knee OA and to identify a panel of
SF circulating miRNAs that can help evaluate the improvement of OA between the preopera-
tive and postoperative periods. Previous studies have focused on the regeneration of cartilage
after HTO with mechanical loading changes. In this study, the screening identified 2 miRNAs,
miR-30c-5p and miR-23a-3p, that were significantly altered after HTO. Moreover, miR-30c-
5p showed a significant correlation with the postoperative pain score. A direct relationship
between miRNA expression and clinical improvement in patients was not definitively demon-
strated by our results. Nonetheless, our results do suggest the potential of these miRNAs as bio-
markers to indicate clinical improvement after HTO.
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